Physiomics PLC
LSE:PYC
Balance Sheet
Balance Sheet Decomposition
Physiomics PLC
Physiomics PLC
Balance Sheet
Physiomics PLC
| Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+489%
|
0
-72%
|
0
+100%
|
0
-63%
|
0
+155%
|
1
+229%
|
1
-5%
|
1
-3%
|
0
-55%
|
0
-37%
|
0
+58%
|
0
-20%
|
0
+37%
|
1
+97%
|
1
-15%
|
1
+108%
|
1
-9%
|
1
-16%
|
1
-40%
|
0
-37%
|
1
+111%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-76%
|
0
+91%
|
0
-5%
|
0
+135%
|
0
-23%
|
0
-61%
|
0
-21%
|
0
N/A
|
0
+9%
|
0
-8%
|
0
-52%
|
0
+86%
|
0
-12%
|
0
+48%
|
0
-33%
|
0
+52%
|
0
+20%
|
0
-11%
|
0
+1%
|
0
-2%
|
0
+43%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
1
|
1
|
6
|
6
|
6
|
6
|
6
|
7
|
7
|
8
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
0
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+74%
|
1
N/A
|
1
-4%
|
1
-4%
|
0
-64%
|
0
-46%
|
0
+133%
|
0
-37%
|
0
+61%
|
1
+110%
|
1
-12%
|
1
+116%
|
1
-11%
|
1
-16%
|
1
-45%
|
0
-47%
|
1
+145%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+489%
|
0
-72%
|
0
+100%
|
0
-63%
|
0
+155%
|
1
+229%
|
1
-5%
|
1
-3%
|
0
-55%
|
0
-37%
|
0
+58%
|
0
-20%
|
0
+37%
|
1
+97%
|
1
-15%
|
1
+108%
|
1
-9%
|
1
-16%
|
1
-40%
|
0
-37%
|
1
+111%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
0
|
2
|
2
|
4
|
4
|
5
|
9
|
11
|
15
|
15
|
17
|
25
|
35
|
57
|
72
|
72
|
96
|
97
|
97
|
97
|
135
|
303
|
|